Complementary and alternative medicine use in glioma patients in France.

Emilie Le RhunPatrick DevosVéronique BourgAmélie DarlixVéronique LorgisGuido AhleMathieu BooneLuc TaillandierElsa CurtitLouis GrasChristine Lebrun FrenayDorothee GramatzkiCarole RamirezNicolas SimonMichael Weller

Published in: Journal of neuro-oncology (2019)

CAM are frequently used by glioma patients in France. Underlying needs and expectations, as well as potential interactions with tumor-specific treatments, and financial and quality of life burden, should be discussed with patients and caregivers.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
young adults
patient reported outcomes
climate change